US2016184379A1PendingUtilityA1
Molecular Combinations for Cancer or Other Disease Treatment
Est. expiryNov 13, 2030(~4.3 yrs left)· nominal 20-yr term from priority
Inventors:Nadav Shraibom
A61K 31/192A61K 36/64A61K 36/355A61K 36/708A61K 31/122A61K 36/804A61K 36/53A61K 36/65A61K 36/286A61K 36/815A61K 31/185A61K 36/36A61K 36/54A61K 31/575A61K 31/7048A61K 36/35A61K 36/315A61K 36/73A61K 36/00A61K 9/0014A61K 33/06A61K 31/7034A61K 45/06A61K 36/77A61K 36/808A61K 36/30
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method and medicine for treating leukemia or other cancer or disease condition including administering periodic doses of a combination of one or more of emodin, rhein or rhapontin with one or more of aucubin, digoxin or beta-sitosterol, and/or one or more of carvacrol, vanillic acid or sitosterol.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of preparing a medicinal combination for treating a patient diagnosed with leukemia, melanoma, psoriasis or breast, prostate or colon cancer, comprising preparing a combination of effective amounts of each of Da Huang, Sheng Di Huang and Jin Yin Hua, wherein the Sheng Di Huang, the Da Huang and the Jin Yin Hua together comprise 57% or more of said combination.
2 . The method of claim 1 , wherein the Sheng Di Huang comprises 33% or more of said combination.
3 . The method of claim 1 , comprising 3.3 grams or more of Da Huang and 13.3 grams or more of Sheng Di Huang and 3.3 grams or more of Jin Yin Hua.
4 . A method of treating a patient diagnosed with leukemia, melanoma, psoriasis or breast, prostate or colon cancer, comprising administering to said patient a combination of effective amounts of each of Da Huang, Sheng Di Huang and Jin Yin Hua, wherein the Sheng Di Huang, the Da Huang and the Jin Yin Hua together comprise 57% or more of said combination.
5 . The method of claim 4 , wherein the Sheng Di Huang comprises 33% or more of said combination.
6 . The method of claim 4 , wherein the combination comprises 3.3 grams or more of Da Huang and 13.3 grams or more of Sheng Di Huang and 3.3 grams or more of Jin Yin Hua.
7 . A medicinal combination for treating a patient diagnosed with leukemia, melanoma, psoriasis or breast, prostate or colon cancer, comprising effective amounts of each of Da Huang, Sheng Di Huang and Jin Yin Hua, wherein the Sheng Di Huang, the Da Huang and the Jin Yin Hua together comprise 57% or more of said medicinal combination.
8 . The medicinal combination of claim 7 , wherein the Sheng Di Huang comprises 33% or more of said medicinal combination.
9 . The medicinal combination of claim 7 , comprising 3.3 grams or more of Da Huang and 13.3 grams or more of Sheng Di Huang and 3.3 grams or more of Jin Yin Hua.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.